Angiotensin I-converting enzyme (ACE) converts inactive angiotensin I (A I) to angiotensin II (A II), a potent vasopressor peptide, by releasing the C-terminal dipeptide, and also inactivates bradykinin, a potent depressor peptide. This enzyme is thought to be located mainly in the lung and to work physiologically in the lung. To elucidate the physiological role of ACE in the lung, the change of the activity of this enzyme in the lung and in plasma of rabbits with experimental pneumonitis was examined.
Experimental pneumonitis was produced by injection of Complete Freund's Adjuvant (acute pneumonitis) and of N-nitroso-N-methylurethane (chronic pneumonitis). ACE activity was measured both in plasma and in pulmonary tissue by a spectrophotometric method using Hippuryl-Histidyl-Leucine. Aerfusion experiment was also done. The lung was perfused with Tyrode solution from pulmonary artery without taking out the lung from the thorax, after ligation of the aorta perfusate was collected from the left ventricle. AI and AII were measured by radioimmunoassay, and BK was measured by biological assay, using the rat uterus.
In acute experiment, ACE activity in lung tissue was significantly decreased, namely, 2997±311nmol/mg prot/min on 2nd day (<0.001), 4930±729nmol/mg prot/min on 7th day (P<0.001), 4530±867nmol/mg prot/min on 14th day (P<0.001) compared with normal lung 6940±323nmol/mg prot/min. Plasma ACE was also decreased from 57.23±3.21nmol/ml/min to 42.41±4.20nmol/ml/min on 2nd day (P<0.05). In the perfusion experiment, conversion of AI to AII and inactivation of BK were significantly decreased, from 81.65±2.84% to 70.76±2.88% (P<0.05) and from 92.20±2.46% to 85.9±1.12% (P<0.001), respectively, in the acute experimental group.
On the other hand, in the chronic pneumonitis group, the activity of conversion of AI to AII and the inactivation of BK was not changed compared with the normal group in the perfusion experiment. ACE activity in lung tissue and in plasma also showed no deviation from normal controls.
In the case of decreased activity of ACE in the lung, less AII will be released into systemic circulation and BK will pass through the pulmonary circulation into systemic circulation, thus this may result in the decrease of systemic blood pressure.
View full abstract